Cian Healthcare Ltd - 542678 - Shareholder Meeting-EGM To Be Held On Saturday, The 13Th Day Of May, 2023.
In compliance with the requirement under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations'), we enclose Notice convening Extraordinary General Meeting of the Members of the Company to be held on Saturday, the 13th day of May, 2023. Cian Healthcare Ltd - 542678 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2023
Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Financial Year ended 31st March 2023 Cian Healthcare Ltd - 542678 - Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Year Ended On 31St March, 2023
As per the Regulation 7(3) of the SEBI (LODR) Regulation, 2015, we are hereby submitting the Compliance Certificate Certifying Maintaining share transfer Facilities as on 31.03.2023. Cian Healthcare Ltd - 542678 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 (erstwhile Regulation 54 of SEBI (Depositories and Participants) Regulations, 1996, we are hereby enclosing a copy of the Certificate received from Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company for the Quarter ended 31st day of March, 2023. Cian Healthcare Ltd - 542678 - Closure of Trading Window
This is to inform you that in accordance with the code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information framed by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended from time to time), the trading window for dealing in the securities of the Company shall be remain closed for all Designated Persons of the Company including their immediate relatives from Saturday, 01st April, 2023 upto 48 hours after the declaration of the financial results of the Company for the period ended March 31st , 2023. Cian Healthcare Ltd - 542678 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Rating pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Cian Healthcare Ltd - 542678 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) OF SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 2022. Cian Healthcare Ltd - 542678 - REVISED SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEPTEMBER, 2022 AS PER REGULATION 33 OF SEBI (LODR) REGULATIONS, 2015.
REVISED SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEPTEMBER, 2022 AS PER REGULATION 33 OF SEBI (LODR) REGULATIONS, 2015. Cian Healthcare Ltd - 542678 - SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL RESULTS OF CIAN HEALTHCARE LIMITED FOR THE HALF YEAR ENDED 30TH SEPTEMBER, 2022 AS PER REGULATION 33 OF SEBI (LODR) REGULATIONS, 2015.
In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 (''Listing Regulations''), please be informed that the Board of Directors at its meeting held on today i.e., Monday, November 14, 2022, to inter alia considered and approved the Un-Audited Financial Results (standalone and consolidated) for the quarter and half year ended September 30, 2022 and took on record the Limited Review Report issued by the Statutory Auditors of the Company. Cian Healthcare Ltd - 542678 - Board Meeting Outcome for OUTCOME OF BOARD MEETING.
In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 (''Listing Regulations''), please be informed that the Board of Directors at its meeting held on today i.e., Monday, November 14, 2022, to inter alia considered and approved the Un-Audited Financial Results (standalone and consolidated) for the quarter and half year ended September 30, 2022 and took on record the Limited Review Report issued by the Statutory Auditors of the Company.